Androgens
Dehydrochloromethyltestosterone
The steroid known as Oral Turinabol has human metabolism evidence that should not be mistaken for a clinical benefit or safety study.
Small controlled human excretion study; evidence checked 2026-10-01
Also known as: DHCMT · Oral Turinabol
Practical use
Evidence interpretation and concrete review questions
- Read the study objective
- Check whether it measured outcomes or only chemical excretion.
- Avoid calendar guarantees
- This small sample demonstrated variability rather than a universal timeline.
- Share exact exposure information
- For a health assessment, the product name and timing are more useful than the word steroid alone.
Overview
Dehydrochloromethyltestosterone, abbreviated DHCMT, is a chlorinated anabolic steroid. The paper reviewed here studied its transformation and urinary metabolites in people, not a training program or medical treatment outcome.
Risks and limitations
No useful human adverse-event rate can be calculated from five volunteers in an excretion experiment. A small analytical study does not establish tolerability of repeated or combined use.
How to read this
Detectable metabolites, active drug in the body and lasting health effects are distinct concepts. This guide deliberately does not turn analytical work into a testing-evasion timetable.
Research explained
Human metabolite identification
Who was studied
Five healthy male volunteers in a controlled administration study, with urinary metabolites examined using mass spectrometry and reference compounds.
What was found
The study confirmed previously proposed metabolites and found substantial differences between volunteers in which markers were most informative.
What it cannot establish
Designed for chemical identification and anti-doping analysis, not efficacy, endocrine recovery or long-term toxicity.
Read the original studyDetection is a property of the whole method
The sample fraction, target metabolite and analytical method influenced the findings. A single parent-drug measurement tells an incomplete story.
Supporting sourceKeep the exact molecule
DHCMT is different from metandienone and methyltestosterone despite structural and naming similarities.
Supporting sourceClaims versus findings
Incorrect
A human administration study automatically proves clinical safety.
This experiment was designed around metabolite detection.
Check the evidenceCommon questions
Does a detectable metabolite prove a current performance effect?
No. Analytical persistence and pharmacological effect are different outcomes.
SourceSources
Human metabolite identification
PubChem chemical identity; checked October 1, 2026
Sources checked 2026-10-01.
General education; not a personal treatment plan.